SCHEMBL17112415

SCHEMBL17112415

O=C(C1CC1)N1CCN(I)CC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
HPGD P15428 2/20 0.60
TSHR P16473 1/20 0.60
CHRNB2 P17787 4/20 0.56
CHRNA3 P32297 4/20 0.56
CHRNA4 P43681 4/20 0.56
CHRNB3 Q05901 3/20 0.56
CHRNA6 Q15825 3/20 0.56
HTT P42858 1/20 0.52
TDP1 Q9NUW8 1/20 0.47
TP53 P04637 1/20 0.47
HSD11B1 P28845 2/20 0.46
LMNA P02545 2/20 0.46
CNR1 P21554 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA7 P36544 1/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20083914 0.91 ALDH1A1 (0.75) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL21844925 0.91 ALDH1A1 (0.68) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL19569940 0.87 ALDH1A1 (0.75) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL2956853 0.87
SCHEMBL19288507 0.84 ALDH1A1 (0.48) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL14301397 0.82 HPGD (0.68) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL24746586 0.81 HTT (0.62) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL24003551 0.79 CHRNB2 (0.48) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL20083911 0.79 HTT (0.46) ALDH1A1HPGDTSHRCHRNB2CHRNA3
SCHEMBL26162910 0.78 HTT (0.46) ALDH1A1HPGDTSHRCHRNB2CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022125925-A1 COMPOSITIONS FOR TREATING DRY AGE-RELATED MACULAR DEGENERATION (AMD) COGNITION THERAPEUTICS, INC. (US) 2022-06-16 WO disclosed
EP-3312160-A1 HEPATITIS B ANTIVIRAL AGENTS Novira Therapeutics Inc. (US) 2018-04-25 EP disclosed
EP-3210609-A1 PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS ARIAD PHARMACEUTICALS, INC. (US) 2017-08-30 EP disclosed
WO-2015140133-A1 PIPERIDINE-DIONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2015-09-24 WO disclosed
WO-2015142903-A2 METHOD OF CONTROLLING LACTATE PRODUCTION WITH PIPERDINE-DIONE DERIVATIVES GENENTECH, INC. (US) 2015-09-24 WO disclosed